about
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 casesChronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France.Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.Chronic alcohol exposure, infection, extended circulating white blood cells differentiated by flow cytometry and neutrophil CD64 expression: a prospective, descriptive study of critically ill medical patientsIn vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.CD1d-restricted peripheral T cell lymphoma in mice and humans.Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 TherapyRefining the white blood cell differential: the first flow cytometry routine application.Toward a reference method for leukocyte differential counts in blood: comparison of three flow cytometric candidate methods.Evaluation of CytoDiff™ on cord blood WBC differential.CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.Integration of Immature Granulocytes Quantification With the Version 2.0 UniCel DxH 800 in the HematoFlow Strategy.Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists.Cyclophosphamide as a first-line therapy in LGL leukemia.Dysfunction of the Fas apoptotic signaling pathway in persistent polyclonal B-cell lymphocytosis.Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage.Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis.Evaluation of whole-blood conservation reagents for Hematoflow-based WBC differential count: Unsatisfactory results.Reply to: Tempering the Clinical Effects of Early Myeloid Derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock.The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients.Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow.Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.Expression of the two alternative [a] and [b] transcripts of CCND1 gene in cyclin D1-expressing B-malignancies: relevance for the pathogenesis.Acute Alcohol Exposure Has an Independent Impact on C-Reactive Protein Levels, Neutrophil CD64 Expression, and Subsets of Circulating White Blood Cells Differentiated by Flow Cytometry in Nontrauma PatientsImprovement of the leukocyte differential performed by flow cytometry using the advanced 2.0 version of the CytoDiff CXP softwareCD64, a Reliable Biomarker of Bacterial Infection in Intensive Care Units?Toward new insights on the white blood cell differential by flow cytometry: A proof of concept study on the sepsis modelCyclin D1 expression in patients with multiple myelomaMutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010Normal levels of peripheral CD19+CD5+ CLL-like cells: Toward a defined threshold for CLL follow-up-A GEIL-GOELAMS study[Mononucleosis, diagnostic approach]Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study
P50
Q24620609-4EB7239F-0E2E-4B42-9D63-C2543FBCC1B1Q30370565-47AFBC28-68CC-4398-88B9-8D56CE41C0B2Q33365754-9B05D5FC-E693-4860-87A2-ECA203B70C28Q35866406-1CF2E88C-15EA-48B9-90AF-251B7C868DF7Q36517382-10DD7D84-5B8B-4D0D-B1AA-E127923265EFQ36715919-CF2A81FB-61B7-49C4-A88A-233A546F4EFFQ36863110-A0C19108-4180-42B2-B5F1-3931B42A6D61Q36963592-E8DF879A-0515-4DEA-8B0E-A7CC16D8BF03Q37761122-C328F2D4-A808-4AC6-BDF7-AF76287CC24AQ38021969-E056F303-CF9B-4DF4-89B2-B711B5D9E7D8Q38031996-483FA633-C430-45FF-B98E-D9A01EC92C65Q38349082-AAB2D7A8-74F5-431A-9AFB-0ADDFA70A001Q38819971-2A00F603-7764-48DF-9675-2737804A8FA3Q39063860-9CFB50EA-70E9-4478-905E-8397EBC95DE9Q39423479-8B55A907-945E-4255-BEDB-042B7732C359Q40350208-DF34FE6D-A3A2-4E35-8353-8D927D012423Q40638845-49DA2735-0FA7-41C5-B4E9-4DF1F1C225D3Q40950798-D44A43B7-562A-452B-9691-581B5C1296C9Q42563534-F1D8C596-E3B2-40A0-9AFB-5A36AD31A9A5Q44327167-181FC8AF-A293-4669-A518-050550C9BB49Q44644708-94A279E3-EED9-430A-B588-E8A3DFAB6E41Q44670719-CC8DED0E-87C0-4C43-9E1F-DE3CA4FDF18EQ47949447-C575D82D-B1DD-4D40-BB6D-1DFCB221A161Q48213685-38FE425C-A102-425E-A185-5B5CEAB374CAQ49563279-B1796C1B-751C-4D33-BF5E-5A2A0F1AA3AEQ50969130-6FA60A97-2966-434D-89C4-B54DCFBE7C02Q52808766-A6C505B5-8C3C-4259-91D5-3D314ED4EB0BQ52881850-DE54856E-313A-4F78-B300-BC313691CF2CQ53791265-235C2C39-2D7B-4F34-8A64-8EE8676C3405Q54707187-CBFF79B3-8BF6-4C9B-9BE0-5521FF5B8D52Q54783414-17599F65-9FC7-4911-8392-727CC2C53ED4Q61053565-CA57DFF5-42A7-4E65-86EC-137BD1616271Q61053566-381A5056-C1A7-4333-8C3D-D1D9CEA0FA3FQ61053570-A362BD28-A3CE-4C24-8D64-927B008E40F5Q61053571-518EAB1D-C136-4874-8D38-D3E2AAB72FAAQ62059264-3DF507FF-2D95-49F5-AB6C-5C99B06DCA01Q63346982-4B306B3B-2C31-40BD-AE63-0792F12ECEFBQ63346985-F48A4D6F-1B22-416D-8F2E-FF511196164DQ81052360-640B532A-ADC1-4987-BCA2-BCF386C65E03Q85654135-5538EF71-EC82-4864-901B-6DEDA26F6F84
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mikael Roussel
@ast
Mikael Roussel
@en
Mikael Roussel
@es
Mikael Roussel
@nl
type
label
Mikael Roussel
@ast
Mikael Roussel
@en
Mikael Roussel
@es
Mikael Roussel
@nl
prefLabel
Mikael Roussel
@ast
Mikael Roussel
@en
Mikael Roussel
@es
Mikael Roussel
@nl
P214
P106
P1153
12807824600
P214
P31
P496
0000-0002-9741-0668
P7859
viaf-214924716